AMJ Global Technology

CIK:0001593773|SEC Filings

Condensed Statements of Operations (Unaudited) - USD ($)	3 Months Ended		9 Months Ended
	Aug. 31, 2025	Aug. 31, 2024	Aug. 31, 2025	Aug. 31, 2024
Condensed Statements of Operations (Unaudited)
Revenues - related party	$ 232	$ 8	$ 674	$ 8
Operating Expenses
General and administrative	1,602	7,120	5,027	10,120
Professional fees	4,891	7,949	39,968	37,622
Management compensation	30,000	35,764	110,000	97,859
Total operating expenses	36,493	50,833	154,995	145,601
Operating loss	(36,261)	(50,825)	(154,321)	(145,593)
Other income (expense)
Interest expense	(11,781)	0	(28,135)	0
Gain on settlement of debt - related party	0	0	0	98,109
Impairment acquisition	(886,232)	0	(886,232)	0
Total other income (expenses)	(898,013)	0	(914,367)	98,109
Net loss before income taxes	(934,274)	(50,825)	(1,068,688)	(47,484)
Provision for income taxes	0	0	0	0
Net Loss	$ (934,274)	$ (50,825)	$ (1,068,688)	$ (47,484)
Basic and diluted income (loss) per common share	$ (0.01)	$ (0.00)	$ (0.01)	$ (0.00)
Basic and diluted weighted average common shares outstanding	106,472,857	104,843,639	107,234,570	103,823,750

Condensed Statements of Cash Flows (Unaudited) - USD ($)	9 Months Ended
	Aug. 31, 2025	Aug. 31, 2024
CASH FLOWS FROM OPERATING ACTIVITIES
Net loss	$ (1,068,688)	$ (47,484)
Adjustments to reconcile net loss to net cash used in operating activities:
Imputed interest	28,134	0
Impairment acquisition	886,232	0
Stock based compensation for services - related party	20,000	1,124
Management stock-based compensation	0	6,735
Gain on settlement of debt - related party	0	(98,109)
Changes in operating assets and liabilities:
Accounts receivable-related party	(625)	(8)
Prepaid expenses	5,000	5,526
Accounts payable and accrued liabilities	6,383	2,643
Accrued expenses - related party	4,500	0
Accrued management fee - related party	90,000	90,000
Net cash used in operating activities	(29,064)	(39,573)
CASH FLOWS FROM FINANCING ACTIVITIES
Proceeds from advances from related party	25,274	39,802
Repayment of advances to related party	(2,326)	0
Contribution from common stock issued	6,000	0
Net cash provided by financing activities	28,948	39,802
Net change in cash for the period	(116)	229
Cash at beginning of period	226	0
Cash at end of period	110	229
SUPPLEMENTAL CASH FLOW INFORMATION:
Cash paid for income taxes	0	0
Cash paid for interest	0	0
NON-CASH INVESTING AND FINANCING ACTIVITIES
Common stock issued for settlement of debt - related party	0	530
Common stock issued for compensation - related party	0	6,735
Common stock issued for services - related party	20,000	1,124
Cancellation software and technology asset, net	3,371	0
Cancellation common stock	2	0
Common stock issued for software and development acquisition	0	3,371
Common stock issued for revenue sharing agreement - related party	$ 0	$ 337

Condensed Balance Sheets - USD ($)	Aug. 31, 2025	Nov. 30, 2024
Current Assets
Cash	$ 110	$ 226
Accounts receivable - related party	664	39
Prepaid expenses	280	5,280
Total Current Assets	1,054	5,545
Medicare contracts asset-related party	0	337
Software and technology assets, net	0	3,371
TOTAL ASSETS	1,054	9,253
Current Liabilities
Accounts payable and accrued liabilities	15,645	4,762
Accrued management fees - related party	270,000	180,000
Due to related party	39,114	16,166
Due to related party-Medicare contracts asset acquisition	914,029	0
Total Current Liabilities	1,238,788	200,928
Total Liabilities	1,238,788	200,928
Stockholders' Deficit
Common stock, $0.001 par value, 750,000,000 shares authorized, 106,472,857 and 107,782,190 shares issued and outstanding, respectively	106,473	107,782
Additional paid-in capital	200,755	176,817
Accumulated deficit	(1,544,962)	(476,274)
Total Stockholders' Deficit	(1,237,734)	(191,675)
TOTAL LIABILITIES AND STOCKHOLDERS' DEFICIT	$ 1,054	$ 9,253